Alkermes to Take Part in Stifel's 3rd Annual CNS Day

<br /> Alkermes to Take Part in Stifel’s 3rd Annual CNS Day<br />

PR Newswire

DUBLIN

,

March 25, 2021

/PRNewswire/ —

Alkermes plc

(Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at Stifel’s 3
^rd
Annual CNS Day on

Thursday, Apr. 1, 2021

at

8:30 a.m. ET

(

1:30 p.m. BST

). The presentation may be accessed under the Investors tab on

www.alkermes.com

and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in

Dublin, Ireland

, Alkermes plc has an R&D center in

Waltham, Massachusetts

; a research and manufacturing facility in Athlone,

Ireland

; and a manufacturing facility in

Wilmington, Ohio

. For more information, please visit Alkermes’

website at

www.alkermes.com

.